---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-22-002674"
form_type: "8-K"
ticker: "ENTXW"
cik: "0001638097"
company_name: "Entera Bio Ltd."
filed_at: "2022-07-18T23:59:59+00:00"
generated_at: "2026-06-24T13:23:18.847049+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Entera Bio appoints Miranda Toledano CEO, Dana Yaacov-Garbeli CFO; former CEO Jamas departs with $411K

## Summary
- Appointed Miranda Toledano as CEO effective July 15, 2022; she had served as CBO/CFO and director since 2018.
- Toledano's amended employment: annual employer cost $380K, bonus eligibility 60% of base salary, option grant of 600K shares at $1.40.
- Additional performance milestone options for 200K shares under long-term incentive.
- Dana Yaacov-Garbeli promoted to CFO effective July 15; she was Israel-based CFO since June 2019.
- Former CEO Spiros Jamas receives lump sum $411,666.67 (13 months salary) and extension of vested option exercise period for 492,832 shares for two years.

## SEC filing metadata
- accession: 0001178913-22-002674
- form_type: 8-K
- ticker: ENTXW
- cik: 0001638097
- company_name: Entera Bio Ltd.
- filed_at: 2022-07-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638097/000117891322002674/0001178913-22-002674-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638097/000117891322002674/zk2228138.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-22-002674
- JSON: https://secwatch.observer/filing/0001178913-22-002674.json
- Plain text: https://secwatch.observer/filing/0001178913-22-002674.txt

## Key facts
- Executive change
  Miranda J. Toledano was appointed as Chief Executive Officer at Entera Bio Ltd..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: appointed Miranda J. Toledano, one of the Company’s existing directors and the Company’s Chief Business Officer, Chief Financial Officer and Head of Corporate Strategy, as the Company’s Chief Executive Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638097/000117891322002674/0001178913-22-002674-index.htm
- Executive change
  Dr. Spiros Jamas departed as Chief Executive Officer at Entera Bio Ltd..
  - Action: separated
  - Role: Chief Executive Officer
  source text: separation from the Company of Dr. Spiros Jamas
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638097/000117891322002674/0001178913-22-002674-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.